Financials data is unavailable for this security.
View more
Year on year Shanghai ZJ Bio-Tech Co Ltd 's revenues fell -88.21% from 2.33bn to 274.33m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 760.27m to a loss of 136.86m.
| Gross margin | 68.92% |
|---|---|
| Net profit margin | -89.26% |
| Operating margin | -102.60% |
| Return on assets | -4.52% |
|---|---|
| Return on equity | -4.75% |
| Return on investment | -4.74% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Shanghai ZJ Bio-Tech Co Ltd fell by 378.19m. Cash Flow from Investing was negative at 77.69m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 81.88m for operations while cash used for financing totalled 234.39m.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 19.64 |
|---|---|
| Tangible book value per share | 19.58 |
More ▼
Balance sheet in CNYView more
| Current ratio | 19.89 |
|---|---|
| Quick ratio | 18.50 |
| Total debt/total equity | 0.0014 |
|---|---|
| Total debt/total capital | 0.0014 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -100.00% and -118.12%, respectively.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -218.69 |
